Stay updated on Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The site revision changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page remains a 403 Forbidden error screen; the footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record details with an access-denied message. This change affects whether the study information is viewable rather than presenting new substantive content.SummaryDifference18%

- Check37 days agoChange DetectedThe page's revision banner changes from v3.6.6 to v3.7.0. This reflects a front-end version update rather than any modification to the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision tag was updated to v3.6.6, replacing the previous v3.6.5 to reflect a new version of the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing v3.6.4, indicating that the page has been updated. This reflects a small metadata/content update to the study record on ClinicalTrials.gov.SummaryDifference0.0%

Stay in the know with updates to Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.